Methylphenidate (MPH): physician's guide to prescribing

Contact



Welcome to the contact page



Please send all website-related enquiries to ApotheCom, 6th Floor, Holborn Gate, 26 Southampton Buildings, London WC2A 1AN.


Please note that this address should only be used for technical queries about the website.


Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medical product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via www.mhra.gov.uk/yellowcard